90 related articles for article (PubMed ID: 17877400)
1. Dendrimer-based BH3 conjugate that targets human carcinoma cells.
Myc A; Patri AK; Baker JR
Biomacromolecules; 2007 Oct; 8(10):2986-9. PubMed ID: 17877400
[TBL] [Abstract][Full Text] [Related]
2. Dendrimer-based targeted delivery of an apoptotic sensor in cancer cells.
Myc A; Majoros IJ; Thomas TP; Baker JR
Biomacromolecules; 2007 Jan; 8(1):13-8. PubMed ID: 17206782
[TBL] [Abstract][Full Text] [Related]
3. PAMAM dendrimer-based multifunctional conjugate for cancer therapy: synthesis, characterization, and functionality.
Majoros IJ; Myc A; Thomas T; Mehta CB; Baker JR
Biomacromolecules; 2006 Feb; 7(2):572-9. PubMed ID: 16471932
[TBL] [Abstract][Full Text] [Related]
4. Targeting and inhibition of cell growth by an engineered dendritic nanodevice.
Thomas TP; Majoros IJ; Kotlyar A; Kukowska-Latallo JF; Bielinska A; Myc A; Baker JR
J Med Chem; 2005 Jun; 48(11):3729-35. PubMed ID: 15916424
[TBL] [Abstract][Full Text] [Related]
5. Poly(amidoamine) dendrimer-based multifunctional engineered nanodevice for cancer therapy.
Majoros IJ; Thomas TP; Mehta CB; Baker JR
J Med Chem; 2005 Sep; 48(19):5892-9. PubMed ID: 16161993
[TBL] [Abstract][Full Text] [Related]
6. Targeting cancer cells with biotin-dendrimer conjugates.
Yang W; Cheng Y; Xu T; Wang X; Wen LP
Eur J Med Chem; 2009 Feb; 44(2):862-8. PubMed ID: 18550227
[TBL] [Abstract][Full Text] [Related]
7. Encapsulation of 2-methoxyestradiol within multifunctional poly(amidoamine) dendrimers for targeted cancer therapy.
Wang Y; Guo R; Cao X; Shen M; Shi X
Biomaterials; 2011 Apr; 32(12):3322-9. PubMed ID: 21315444
[TBL] [Abstract][Full Text] [Related]
8. BH3 peptidomimetics potently activate apoptosis and demonstrate single agent efficacy in neuroblastoma.
Goldsmith KC; Liu X; Dam V; Morgan BT; Shabbout M; Cnaan A; Letai A; Korsmeyer SJ; Hogarty MD
Oncogene; 2006 Aug; 25(33):4525-33. PubMed ID: 16568093
[TBL] [Abstract][Full Text] [Related]
9. Molecular heterogeneity analysis of poly(amidoamine) dendrimer-based mono- and multifunctional nanodevices by capillary electrophoresis.
Shi X; Majoros IJ; Patri AK; Bi X; Islam MT; Desai A; Ganser TR; Baker JR
Analyst; 2006 Mar; 131(3):374-81. PubMed ID: 16496045
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, characterization and stability of a luteinizing hormone-releasing hormone (LHRH)-functionalized poly(amidoamine) dendrimer conjugate.
Bi X; Shi X; Baker JR
J Biomater Sci Polym Ed; 2008; 19(1):131-42. PubMed ID: 18177559
[TBL] [Abstract][Full Text] [Related]
11. Preparation, cellular transport, and activity of polyamidoamine-based dendritic nanodevices with a high drug payload.
Kolhe P; Khandare J; Pillai O; Kannan S; Lieh-Lai M; Kannan RM
Biomaterials; 2006 Feb; 27(4):660-9. PubMed ID: 16054211
[TBL] [Abstract][Full Text] [Related]
12. Tailor-made approach to photodynamic therapy in the treatment of cancer based on Bcl-2 photodamage.
Usuda J; Hirata T; Ichinose S; Ishizumi T; Inoue T; Ohtani K; Maehara S; Yamada M; Tsutsui H; Okunaka T; Kato H; Ikeda N
Int J Oncol; 2008 Oct; 33(4):689-96. PubMed ID: 18813781
[TBL] [Abstract][Full Text] [Related]
13. HPLC analysis of PAMAM dendrimer based multifunctional devices.
Islam MT; Majoros IJ; Baker JR
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Aug; 822(1-2):21-6. PubMed ID: 15950555
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, characterization, and in vitro testing of superparamagnetic iron oxide nanoparticles targeted using folic Acid-conjugated dendrimers.
Landmark KJ; Dimaggio S; Ward J; Kelly C; Vogt S; Hong S; Kotlyar A; Myc A; Thomas TP; Penner-Hahn JE; Baker JR; Holl MM; Orr BG
ACS Nano; 2008 Apr; 2(4):773-83. PubMed ID: 19206610
[TBL] [Abstract][Full Text] [Related]
15. HER2 specific tumor targeting with dendrimer conjugated anti-HER2 mAb.
Shukla R; Thomas TP; Peters JL; Desai AM; Kukowska-Latallo J; Patri AK; Kotlyar A; Baker JR
Bioconjug Chem; 2006; 17(5):1109-15. PubMed ID: 16984117
[TBL] [Abstract][Full Text] [Related]
16. Capillary electrophoresis of poly(amidoamine) dendrimers: from simple derivatives to complex multifunctional medical nanodevices.
Shi X; Majoros IJ; Baker JR
Mol Pharm; 2005; 2(4):278-94. PubMed ID: 16053331
[TBL] [Abstract][Full Text] [Related]
17. Biotinylated poly(amido)amine (PAMAM) dendrimers as carriers for drug delivery to ovarian cancer cells in vitro.
Yellepeddi VK; Kumar A; Palakurthi S
Anticancer Res; 2009 Aug; 29(8):2933-43. PubMed ID: 19661298
[TBL] [Abstract][Full Text] [Related]
18. Involvement of both extrinsic and intrinsic apoptotic pathways in apoptosis induced by genistein in human cervical cancer cells.
Kim SH; Kim SH; Lee SC; Song YS
Ann N Y Acad Sci; 2009 Aug; 1171():196-201. PubMed ID: 19723056
[TBL] [Abstract][Full Text] [Related]
19. HPLC analysis of functionalized poly(amidoamine) dendrimers and the interaction between a folate-dendrimer conjugate and folate binding protein.
Shi X; Bi X; Ganser TR; Hong S; Myc LA; Desai A; Holl MM; Baker JR
Analyst; 2006 Jul; 131(7):842-8. PubMed ID: 16802031
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and characterization of G5 PAMAM dendrimer containing daunorubicin for targeting cancer cells.
Yue Y; Eun JS; Lee MK; Seo SY
Arch Pharm Res; 2012 Feb; 35(2):343-9. PubMed ID: 22370789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]